[Experiences with a Pseudomonas immunoglobulin in ventilated patients with Pseudomonas pneumonia in a surgical intensive care station].
In a clinical trial, the efficacy of a Pseudomonas immunoglobulin was studied in ten ventilated patients suffering from Pseudomonas pneumonia. Compared to ten patients of a previous study who had received a polyvalent immunoglobulin (control group), patients treated with Pseudomonas immunoglobulin fared better with respect to clinical success and duration of treatment, the period of antibiotic treatment being significantly shorter than in the control group.
D000328:Adult; D000368:Aged; D002986:Clinical Trials as Topic; D003428:Cross Infection / Q000628:therapy*; D005260:Female; D006801:Humans; D007074:Immunoglobulin G / Q000627:therapeutic use*; D007262:Infusions, Intravenous; D007362:Intensive Care Units; D008297:Male; D008875:Middle Aged; D011014:Pneumonia / Q000628:therapy*; D011552:Pseudomonas Infections / Q000628:therapy*; D011550:Pseudomonas aeruginosa / Q000276:immunology*; D012121:Respiration, Artificial
D007074:Immunoglobulin G
Erfahrungen mit einem Pseudomonas-Immunglobulin bei beatmeten Patienten mit Pseudomonas-Pneumonie auf einer chirurgischen Intensivstation.